Lessons from the Ebola Outbreak: Designing Vaccine Trials for Emerging Diseases

Friday, February 12, 2016: 10:00 AM-11:30 AM
Marriott Balcony B (Marriott Wardman Park)
Evaluating new vaccines and drugs, whether during an outbreak or for emerging infectious diseases, poses many challenges. The timeline for evaluation is compressed, while humanitarian needs can be great. This session considers the logistical, design, and regulatory aspects of evaluating Ebola vaccine candidates and draws lessons for future outbreaks and emerging infectious diseases.
M. Elizabeth Halloran, University of Washington
Jon Cohen, AAAS/Science
Ana Maria Henao-Restrepo, World Health Organization
Challenges of International Coordination of Vaccine Trials During an Outbreak
Philip Krause, U.S. Food and Drug Administration
Regulatory Challenges During Acute Outbreaks of Emerging Infectious Diseases